Company Overview

Update
Founded:
2008
Headquarters:
New York, NY
Funding:
$28.8M
Categories:
Biotechnology
Description:
ContraFect is a biotechnology company researching the use of monoclonal antibodies to treat life-threatening infectious diseases.

Detailed Description

Update

ContraFect is a biotechnology company pioneering the use of monoclonal antibodies to treat life-threatening infectious diseases.

Current Team (3)

Update

Past Team (2)

Update

Funding Rounds (3) - $28.8M

Update

Investors (2)

Update

Offices/Locations (1)

Update
  • Office

    469 7th Avenue

    3rd Floor

    New York, NY 10018

    USA

News (3)

Update